Symptomtext
Mild Asthma; 3 patients received Pfizer covid 19 vaccine orange cap past the expiration date.; Additional Vaccines Administered on Same Date of the Pfizer Suspect: T-DAP -Sanofi, HPV - Merck, Influenza -Sanofi; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team, Program ID. An 11-year-old female patient received BNT162b2 (BNT162B2), on 05Oct2022 at 16:30 as dose 1 (orange cap), 0.2 ml single (Lot number: FL8095, Expiration Date: 31Aug2022) at the age of 11 years intramuscular, in left deltoid for covid-19 immunisation; influenza vaccine (INFLUENZA), on 05Oct2022 as dose 7, single (Lot number: UT7701KA, Expiration Date: 30Jun2023) intramuscular, in right deltoid for immunisation; hpv vaccine (HPV VACCINE), on 05Oct2022 as dose 1, single (Lot number: 1780878, Expiration Date: 02Dec2023) intramuscular, in right deltoid for immunisation; diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP), on 05Oct2022 as dose 1, single (Lot number: U7461AA, Expiration Date: 12Jul2024) intramuscular, in left deltoid for immunisation. The patient's relevant medical history included: "Allergy" (unspecified if ongoing), notes: She takes allergy meds but that was about it. The patient took concomitant medications. Vaccination history included: Influenza vaccine (Dose Number: 01, Sanofi), for Immunization; Influenza vaccine (Dose Number: 02, Sanofi), for Immunization; Influenza vaccine (Dose Number: 03, Sanofi), for Immunization; Influenza vaccine (Dose Number: 04, Sanofi), for Immunization; Influenza vaccine (Dose Number: 05, Sanofi), for Immunization; Influenza vaccine (Dose Number: 06, Sanofi), for Immunization. The following information was reported: EXPIRED PRODUCT ADMINISTERED (non-serious) with onset 05Oct2022 at 16:30, outcome "unknown", described as "3 patients received Pfizer covid 19 vaccine orange cap past the expiration date."; PRODUCT USE ISSUE (non-serious) with onset 05Oct2022 at 16:30, outcome "unknown", described as "Additional Vaccines Administered on Same Date of the Pfizer Suspect: T-DAP -Sanofi, HPV - Merck, Influenza -Sanofi"; ASTHMA (non-serious), outcome "unknown", described as "Mild Asthma". Therapeutic measures were not taken as a result of asthma. Additional information: The patient did not administer any other vaccinations within four weeks prior to the first administration date of the suspect vaccine and no AE(s) following prior vaccinations. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201223008 same reporter/drug/event, different patient;US-PFIZER INC-202201223295 same reporter/drug/event, different patient;